Biomind Labs Inc.
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Efficacy of Sublingual 5-MeO-DMT for Reducing Anxiety and Depression in MCI (NCT06812221) | Biomind Labs Inc. | 2024-12-15 |
| Safety, Tolerability, and Efficacy of Sublingual Microdoses of 5-MeO-DMT for Depression and Anxiety (NCT06816667) | Biomind Labs Inc. | 2024-10-21 |
| Clinical Study of DMT in Healthy Adults (NCT05573568) | Biomind Labs Inc. | 2022-06-01 |
Track Biomind Labs Inc. automatically
Every clearance here is in the API, with alerts when new ones post.